Experts advise against prescriptive FDA policies for regulating AI

In this article:

• Experts advise that future AI regulations by the FDA should avoid being overly prescriptive.
• They emphasize the need for increased collaboration between industry partners to develop best practices for AI use.
• At the RAPS Regulatory Intelligence Conference on 7 June, experts highlighted the importance of the pharmaceutical and medical device industries being clear about their AI goals.